Medication info
Tradjian Tablet 25/5 mg (Empagliflozin, Linagliptin)

Tradjian Tablet 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tabletLinagliptin›5mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Light pink triangular film-coated tablet
Packaging
10 tablets/PPT [(10 tablets/PPT x 1)], 30 tablets/PPT [(10 tablets/PPT x 3)], 30 tablets/bottle
Approval status
Active

MFDS item code 202302839 · Approved 2023.09.27

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the regularly scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is a treatment that helps control blood glucose in patients with type 2 diabetes by using Empagliflozin and Linagliptin together. It aids in effectively managing blood glucose when combined with dietary control and exercise therapy.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the regularly scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.

Precautions

This medication should not be administered to certain patients. For example, individuals who are allergic to the main ingredients or components of this drug, patients with type 1 diabetes, diabetic ketoacidosis, and those undergoing dialysis should not use this medication. Patients with impaired renal function may experience altered effectiveness of this drug, so renal function should be assessed before administration and monitored regularly. Additionally, it should only be used cautiously in patients with mild to moderate heart failure and is not recommended for patients with severe heart failure. This medication may cause rare skin conditions such as acute pancreatitis or bullous pemphigoid, so if such symptoms occur, discontinue use immediately and consult a physician. The most common side effect is a urinary tract infection, and other effects such as hypoglycemia, dehydration, skin rash, and increased urination may occur. Care should be taken as the risk of hypoglycemia may increase when taken together with insulin or sulfonylureas. Serious metabolic acidosis called ketoacidosis may occur, so during the use of this medication, if symptoms such as nausea, vomiting, abdominal pain, or shortness of breath arise, inform medical professionals immediately. Elderly patients, those with low blood pressure, and individuals at risk for fluid loss should be cautious of dehydration and hypotension when taking this medication, and may temporarily discontinue use if necessary. Furthermore, this medication may increase the risk of genital infections, so those with a history of infections should monitor symptoms closely and seek treatment if needed. Pregnant or breastfeeding women are advised not to take this medication, and breastfeeding should be discontinued if taking this medication. It is not recommended for children and adolescents under 18 years of age, as safety and efficacy have not been established. In case of overdose, seek medical attention immediately, and information on whether hemodialysis can remove this drug's components is limited. Finally, this medication should be kept out of reach of children and stored in its original container to maintain its quality.

Side effects

  • Urinary tract infection
  • vulvar vestibulitis
  • vulvitis
  • balanitis
  • genital infection
  • hypersensitivity reactions
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 187 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer
  • pruritus
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • epigastric pain
  • enterocolitis
  • bowel obstruction
  • gastritis
  • shingles
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • stuttering
  • Alzheimer's type dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot disease
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage kidney disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • pneumonia
  • hyperglycemia
  • dyspnea
  • epistaxis
  • oropharyngeal pain
  • voice disorder
  • allergic rhinitis
  • exercise-induced dyspnea
  • wet cough
  • nasal discharge
  • pulmonary mass
  • arthralgia
  • osteoporosis
  • arthropathy
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • increased serum triglycerides
  • increased urine albumin/creatinine ratio
  • positive urine leukocytes
  • decreased hemoglobin
  • increased serum potassium
  • increased serum creatinine
  • increased serum creatine phosphokinase
  • increased ALT
  • increased serum triglycerides
  • diarrhea
  • vomiting
  • gastritis
  • irritable bowel syndrome
  • abdominal pain
  • gastrointestinal disturbances
  • dysphagia
  • gastric ulcer
  • gum bleeding
  • hemorrhoids
  • lower abdominal pain
  • acute pyelonephritis
  • vitiligo
  • rhinitis
  • soft tissue infection
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • viral upper respiratory infection
  • tonsillitis
  • headache
  • stuttering
  • drowsiness
  • weakness
  • chest discomfort
  • insomnia
  • depression
  • anxiety
  • hypotension
  • flushing
  • hearing loss
  • erectile dysfunction
  • thyroid goiter
  • anemia
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • obesity
  • hyponatremia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • traction retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • age-related dyspnea
  • wet cough
  • sputum retention
  • skin laceration
  • rib fracture
  • iliotibial band syndrome
  • palpitations
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • unstable angina
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius. This ensures the medication's efficacy is preserved safely.

Appearance and packaging

Appearance

Light pink triangular film-coated tablet

Package unit

10 tablets/PPT [(10 tablets/PPT x 1)], 30 tablets/PPT [(10 tablets/PPT x 3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.